Lantern Pharma (NASDAQ:LTRN – Get Free Report) is projected to post its quarterly earnings results before the market opens on Monday, March 17th. Analysts expect Lantern Pharma to post earnings of ($0.59) per share for the quarter.
Lantern Pharma Stock Performance
LTRN opened at $3.80 on Friday. Lantern Pharma has a 52-week low of $2.79 and a 52-week high of $11.99. The firm has a market capitalization of $40.98 million, a PE ratio of -2.13 and a beta of 1.64. The business’s 50-day simple moving average is $4.27 and its 200 day simple moving average is $3.78.
About Lantern Pharma
Featured Stories
- Five stocks we like better than Lantern Pharma
- What is the FTSE 100 index?
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- 3 Warren Buffett Stocks to Buy Now
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- How to buy stock: A step-by-step guide for beginners
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Lantern Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantern Pharma and related companies with MarketBeat.com's FREE daily email newsletter.